Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.31 USD | +2.84% | -0.63% | +32.24% |
05-13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.24% | 2.23B | |
-4.67% | 12.33B | |
-5.19% | 8.14B | |
+28.50% | 5.62B | |
-8.09% | 4.24B | |
-55.31% | 3.06B | |
+13.49% | 2.76B | |
-1.34% | 2.41B | |
-3.55% | 1.87B | |
+3.02% | 1.58B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics Shares Climb as Q3 Loss Narrower Than Estimated, FY Revenue Guidance Raised